Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead’s Yescarta Growth Continues, But Momentum Slowed

Oct 25 2018

• By Joseph Haas

US-Money-and-Pills_V2_1200x675

Additional Topics

Sales & Earnings ImmunoOncology Business Strategies Commercial Cancer Infectious Diseases BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window